Welcome to the video section of the NCRI Cancer conference website. Please select a section from the list below.
- 2009 NCRI Conference: Overview of the Conference
- 2009 NCRI Conference: Focus on the Trade Exhibition
- 2009 NCRI Conference: Patient and public ('Consumer') involvement
- Trevor Walker, director of The Cancer Tales - a play based on people's experiences of cancer, performed at the NCRI Cancer Conference.
- Dr Larry Norton, Memorial Sloan-Kettering Cancer Centre, New York, USA - The 'self-seeding' concept of cancer spread
- Dr Chris Nutting, The Royal Marsden Hospital - The PARSPORT trial, a new radiotherapy technique for treating head and neck cancer.
- Professor Caroline Dive, Paterson Institute for Cancer Research, Manchester - Circulating tumour cells and biomarkers
- Professor Mike Richards, National Cancer Director - Difficult decisions: End of life care
- Professor Martin Glennie and Dr Juliet Gray, University of Southampton - Immunotherapy for treating childhood neuroblastoma
- Dr Jim Norman, Beatson Institute for Cancer Research, Glasgow - Linking p53 and cancer spread
- Professor Ian Tannock, Princess Margaret Hospital, Toronto - The need for better clinical trials for cancer treatments
- Dr Ester Hammond, Gray Institute for Radiation Oncology and Biology, Oxford - New uses for PARP inhibitors
- Dr Jane Maher, Macmillan Cancer Support – Surviving cancer
- Professor Mike Bennett – Lancaster University – Improving pain relief for people with cancer
- Professor Paul Workman, The Institute of Cancer Research
– Drugging the cancer genome - Professor Ron Laskey, University of Cambridge
– 2009 conference summary - (Prior to the 2009 NCRI Cancer Conference) Professor Ken Calman talks about the upcoming NCRI Cancer Conference in Birmingham, 4th-7th October 2009.
NCRI Cancer Conference at ecancer.tv
About the National Cancer Research Institute
- The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry which promotes
co-operation in cancer research among the 21 member organisations for the benefit of patients, the public and the scientific community.
